Lumexa Imaging (NASDAQ:LMRI) Trading Down 5.9% – What’s Next?

Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) traded down 5.9% on Wednesday . The stock traded as low as $9.36 and last traded at $9.4050. 651,995 shares changed hands during trading, a decline of 22% from the average session volume of 832,275 shares. The stock had previously closed at $9.99.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the stock. Raymond James Financial upgraded shares of Lumexa Imaging from an “outperform” rating to a “strong-buy” rating and set a $23.00 price objective on the stock in a research report on Monday, February 9th. Barclays lowered their price objective on shares of Lumexa Imaging from $23.00 to $15.00 and set an “overweight” rating on the stock in a research report on Tuesday. One investment analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the company. According to MarketBeat, Lumexa Imaging currently has an average rating of “Strong Buy” and an average price target of $19.00.

Lumexa Imaging Trading Up 6.6%

The firm’s fifty day simple moving average is $12.21.

Lumexa Imaging (NASDAQ:LMRI) last posted its quarterly earnings results on Thursday, March 26th. The company reported ($0.66) EPS for the quarter, missing the consensus estimate of $0.05 by ($0.71). The firm had revenue of $1.02 billion for the quarter, compared to analyst estimates of $262.72 million.

Hedge Funds Weigh In On Lumexa Imaging

Several institutional investors and hedge funds have recently modified their holdings of the stock. T. Rowe Price Investment Management Inc. purchased a new position in shares of Lumexa Imaging during the 4th quarter valued at $37,139,000. Invesco Ltd. purchased a new position in shares of Lumexa Imaging during the 4th quarter valued at $26,562,000. Zimmer Partners LP bought a new stake in Lumexa Imaging in the fourth quarter worth $11,285,000. Readystate Asset Management LP bought a new stake in Lumexa Imaging in the fourth quarter worth $2,590,000. Finally, RTW Investments LP bought a new stake in Lumexa Imaging in the fourth quarter worth $12,025,000.

Lumexa Imaging Company Profile

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).